|
|
Article: Hana Biosciences a Bit Early - Analyst Blog
- Article from:
- Zacks Investment Research - Analyst Blog
- Article date:
- September 4, 2008
- Author:
CopyrightCopyright 2008 Zacks Investment Research. (Hide copyright information)
|
Hana Biosciences a Bit Early - Analyst Blog
Hana Biosciences Inc.
(
HNAB
) has a relatively diversified portfolio but all candidates are in either early stage or middle stage of development. We don't see huge upside potential for Hana shares in the next 6 to 12 months.
The company's cash position is also a matter of concern. As of June 30, Hana had aggregate cash and cash equivalents and available-for-sale securities of $9.3 million. When the company advances its candidates into late stage clinical trials, research and development costs will soar in the next few years. Hana may need to tap the capital market as early as in ...
Related newspaper, magazine, and journal articles:
|
|
Article: In- Depth Research on Hana Biosciences Inc.
M2 Presswire;
April 20, 2007 ;
700+ words
... ... Biotech News: In- Depth Research on Hana Biosciences Inc(C)1994-2007 M2 COMMUNICATIONS ... RDATE:20042007 In- Depth Research on Hana Biosciences Inc (NASDAQ:HNAB) Hana Biosciences, Inc. is a South San Francisco, CA ...
|
|